安必平：股东诸暨高特佳及其一致行动人拟减持不超过约94万股

Group 1 - The core point of the article is that Anbiping (SH 688393) announced a share reduction plan by its major shareholders, which may impact the stock price and market perception of the company [1] - As of the announcement date, shareholders including Zhuhai Gaotejia Ruian Investment Partnership and others hold approximately 6.73% of Anbiping's total shares, amounting to about 6.29 million shares [1] - The shareholders plan to reduce their holdings by up to approximately 940,000 shares, which is not more than 1% of the company's total share capital, within three months starting 15 trading days after the announcement [1] Group 2 - Anbiping's revenue composition for the year 2024 is projected to be 98.73% from in vitro diagnostics and 1.27% from other businesses [1] - The current market capitalization of Anbiping is reported to be 2.4 billion yuan [2]